References
- Ljungberg B, Campbell SC, Choi HY, et al. The epidemiology of renal cell carcinoma. Eur Urol. 2011;60:615–621.
- NORDCAN. Cancer incidence, mortality, prevalence and survival in the Nordic countries, Version 7.3 (08.07.2016); 2016. Available from: http://www.ancr.nu
- Guðmundsson E, Hellborg H, Lundstam S, et al. Metastatic potential in renal cell carcinomas </=7 cm: Swedish Kidney Cancer Quality Register data. Eur Urol. 2011;60:975–982.
- Sand KE, Hjelle KM, Rogde AJ, et al. Incidentally detected renal cell carcinomas are highly associated with comorbidity and mortality unrelated to renal cell carcinoma. Scand J Urol. 2013;47:462–471.
- Ljungberg B, Hedin O, Lundstam S, et al. Nephron sparing surgery associated with better survival than radical nephrectomy in patients treated for unforeseen benign renal tumors. Urology. 2016;93:117–123.
- The European Association of Urology (EAU) Renal Cell Cancer Guidelines. 2016 ed. 2016. Available from: http://uroweb.org/guideline/renal-cell-carcinoma/
- Thorstenson A, Harmenberg U, Lindblad P, et al. Impact of quality indicators on adherence to National and European guidelines for renal cell carcinoma. Scand J Urol. 2016;50:2–8.
- ICD-10, version 2015; 2015. Available from: http://apps.who.int/classifications/icd10/browse/2015/en
- NOMESCO Classification of Surgical Procedures, version 1.15. Nordic Medico-Statistical Commitee; 2010.
- Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–196.
- Yang G, Villalta JD, Meng MV, et al. Evolving practice patterns for the management of small renal masses in the USA. BJU Int. 2012;110:1156–1161.
- Ljungberg B, Gudmundsson E, Christensen S, et al. Practice patterns for the surgical treatment of T1 renal cell carcinoma: a nationwide population-based register study. Scand J Urol. 2014;48:445–452.
- Scosyrev E, Messing EM, Sylvester R, et al. Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. Eur Urol. 2014;65:372–377.
- Van Poppel H, Da Pozzo L, Albrecht W, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2011;59:543–552.
- Lane BR, Campbell SC, Demirjian S, et al. Surgically induced chronic kidney disease may be associated with a lower risk of progression and mortality than medical chronic kidney disease. J Urol. 2013;189:1649–1655.
- Lane BR, Demirjian S, Derweesh IH, et al. Survival and functional stability in chronic kidney disease due to surgical removal of nephrons: importance of the new baseline glomerular filtration rate. Eur Urol. 2015;68:996–1003.
- Parker D, Kutikov A, Uzzo RG, et al. Understanding chronic kidney disease of surgical versus medical origin: the missing link to the partial versus radical nephrectomy debate? Eur Urol. 2015;68:1004–1006.
- Njurcancer. Nationell kvalitetsregisterrapport 2015: Regionala Cancercentrum i samverkan; 2016.
- Gill IS, Aron M, Gervais DA, et al. Clinical practice. Small renal mass. N Engl J Med. 2010;362:624–634.
- Nisen H, Jarvinen P, Kilpelainen T, et al. Hand-assisted laparoscopic versus open partial nephrectomy in patients with T1 renal tumor: comparative perioperative, functional and oncological outcome. Scand J Urol. 2015;49:446–452.
- Capitanio U, Volpe A. Renal tumor biopsy: more dogma belied. Eur Urol. 2015;68:1014–1015.
- Kim SP, Leibovich BC, Shah ND, et al. The relationship of postoperative complications with in-hospital outcomes and costs after renal surgery for kidney cancer. BJU Int. 2013;111:580–588.
- Hjelle KM, Johannesen TB, Beisland C. Postoperative 30-day mortality rates for kidney cancer are dependent on hospital surgical volume: results from a Norwegian population-based study. Eur Urol Focus 2016. doi: 10.1016/j.euf.2016.10.001
- Sun M, Bianchi M, Trinh QD, et al. Hospital volume is a determinant of postoperative complications, blood transfusion and length of stay after radical or partial nephrectomy. J Urol. 2012;187:405–410.
- Stang A, Buchel C. Renal surgery for kidney cancer in Germany 2005-2006: length of stay, risk of postoperative complications and in-hospital death. BMC Urol. 2014;14:74.
- Becker A, Bianchi M, Hansen J, et al. Benefit in regionalization of care for patients treated with nephrectomy: a Nationwide Inpatient Sample. World J Urol. 2014;32:1511–1521.
- Begg CB, Cramer LD, Hoskins WJ, et al. Impact of hospital volume on operative mortality for major cancer surgery. Jama. 1998;280:1747–1751.
- Abouassaly R, Finelli A, Tomlinson GA, et al. Volume-outcome relationships in the treatment of renal tumors. J Urol. 2012;187:1984–1988.
- Wong SL, Revels SL, Yin H, et al. Variation in hospital mortality rates with inpatient cancer surgery. Ann Surg. 2015;261:632–636.
- Trinh QD, Bianchi M, Hansen J, et al. In-hospital mortality and failure to rescue after cytoreductive nephrectomy. Eur Urol. 2013;63:1107–1114.